174 related articles for article (PubMed ID: 3022916)
1. Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells.
Gulino A; Barrera G; Vacca A; Farina A; Ferretti C; Screpanti I; Dianzani MU; Frati L
Cancer Res; 1986 Dec; 46(12 Pt 1):6274-8. PubMed ID: 3022916
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships of calmodulin antagonism by triphenylethylene antiestrogens.
Barrera G; Screpanti I; Paradisi L; Parola M; Ferretti C; Vacca A; Farina A; Dianzani MU; Frati L; Gulino A
Biochem Pharmacol; 1986 Sep; 35(17):2984-6. PubMed ID: 3017367
[No Abstract] [Full Text] [Related]
3. Antagonism of estrogen receptor and calmodulin association by antiestrogens is not dependent on an interaction with calmodulin.
Rowlands MG; Grimshaw R; Jarman M; Bouhoute A; Leclercq G
Biochem Pharmacol; 1997 Jan; 53(2):241-4. PubMed ID: 9037257
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of protein kinase C and calmodulin by the geometric isomers cis- and trans-tamoxifen.
O'Brian CA; Ioannides CG; Ward NE; Liskamp RM
Biopolymers; 1990 Jan; 29(1):97-104. PubMed ID: 2158363
[TBL] [Abstract][Full Text] [Related]
5. Points of action of estrogen antagonists and a calmodulin antagonist within the MCF-7 human breast cancer cell cycle.
Musgrove EA; Wakeling AE; Sutherland RL
Cancer Res; 1989 May; 49(9):2398-404. PubMed ID: 2706627
[TBL] [Abstract][Full Text] [Related]
6. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen.
Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R
Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017
[TBL] [Abstract][Full Text] [Related]
7. [Effects of antiestrogens and medroxyprogesterone acetate on the clonogenic growth of tamoxifen-sensitive and resistant human breast cancer cells].
Nomura Y; Tashiro H; Takaeko F
Gan To Kagaku Ryoho; 1985 Apr; 12(4):844-50. PubMed ID: 3157351
[TBL] [Abstract][Full Text] [Related]
8. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
Sheen YY; Ruh TS; Mangel WF; Katzenellenbogen BS
Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
[TBL] [Abstract][Full Text] [Related]
9. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
Miller MA; Lippman ME; Katzenellenbogen BS
Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
[TBL] [Abstract][Full Text] [Related]
10. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
Lippman M; Bolan G; Huff K
Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
[TBL] [Abstract][Full Text] [Related]
11. Effects of tamoxifen, tamoxifen metabolites, and nafoxidine on adenosine 3',5'-monophosphate phosphodiesterase: correlations with growth inhibitory activities but not estrogen receptor affinities.
Fanidi A; Courion-Guichardaz C; Fayard JM; Pageaux JF; Laugier C
Endocrinology; 1989 Sep; 125(3):1187-93. PubMed ID: 2547579
[TBL] [Abstract][Full Text] [Related]
12. Partial antagonism between steroidal and nonsteroidal antiestrogens in human breast cancer cell lines.
Müller V; Jensen EV; Knabbe C
Cancer Res; 1998 Jan; 58(2):263-7. PubMed ID: 9443403
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
[TBL] [Abstract][Full Text] [Related]
14. Homologs of idoxifene: variation of estrogen receptor binding and calmodulin antagonism with chain length.
Hardcastle IR; Rowlands MG; Grimshaw RM; Houghton J; Jarman M
J Med Chem; 1996 Feb; 39(4):999-1004. PubMed ID: 8632423
[TBL] [Abstract][Full Text] [Related]
15. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.
Osborne CK; Hobbs K; Clark GM
Cancer Res; 1985 Feb; 45(2):584-90. PubMed ID: 3967234
[TBL] [Abstract][Full Text] [Related]
16. Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3',5'-monophosphate in MCF7 cells.
Chalbos D; Philips A; Galtier F; Rochefort H
Endocrinology; 1993 Aug; 133(2):571-6. PubMed ID: 8344199
[TBL] [Abstract][Full Text] [Related]
17. Variation of the inhibition of calmodulin dependent cyclic AMP phosphodiesterase amongst analogues of tamoxifen; correlations with cytotoxicity.
Rowlands MG; Parr IB; McCague R; Jarman M; Goddard PM
Biochem Pharmacol; 1990 Jul; 40(2):283-9. PubMed ID: 2165403
[TBL] [Abstract][Full Text] [Related]
18. Characterization of MCF 7 breast cancer cell growth inhibition by the antiestrogen nitromifene (CI 628) and selected metabolites.
Ruenitz PC; Thompson CB; Srivatsan V
J Steroid Biochem; 1989 Sep; 33(3):365-9. PubMed ID: 2550704
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of growth inhibition by nonsteroidal antioestrogens in human breast cancer cells.
Sutherland RL; Watts CK; Hall RE; Ruenitz PC
J Steroid Biochem; 1987; 27(4-6):891-7. PubMed ID: 3695509
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of growth and invasiveness of MCF-7 breast cancer cells by antiestrogens.
Thompson EW; Reich R; Shima TB; Albini A; Graf J; Martin GR; Dickson RB; Lippman ME
Cancer Res; 1988 Dec; 48(23):6764-8. PubMed ID: 2846159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
